
ABK Biomedical
Developer of a microsphere product designed to improve the treatment of hypervascular tumors. The company's product is a novel radiopaque bland embolic and beta radiation emitting agent that helps to ...
Valuation
$0
Share Price
N/A
Total Raised
$121.7M
Last Round
N/A